Population pharmacokinetics of faropenem in healthy human volunteers and patients

@article{Hirooka2005PopulationPO,
  title={Population pharmacokinetics of faropenem in healthy human volunteers and patients},
  author={Hideki Hirooka and Masahiro Sou and Koji Miyata and Kohya Shiba and Yusuke Tanigawara},
  journal={Rinsho Yakuri\/japanese Journal of Clinical Pharmacology and Therapeutics},
  year={2005},
  volume={36},
  pages={197-207}
}
Faropenem (FRPM) is an oral penem antibacterial medicine with a high stability to beta-lactamase which has a broad antibacterial spectrum and a strong antibacterial activity to gram positive bacteria, and gram negative bacteria, except for Pseudomonas aeruginosa and anaerobic bacteria. The sale of faropene was started in 1997.Based on the plasma faropenem concentration vs. time data obtained from clinical trials using healthy adult volunteers and patients, and a post-marketing clinical study… 
1 Citations

References

SHOWING 1-4 OF 4 REFERENCES
Population pharmacokinetic modeling and model validation of a spicamycin derivative, KRN5500, in phase 1 study
TLDR
The KRN5500 plasma concentration versus time data obtained from the phase 1 study were well described by the population pharmacokinetic model, and further evaluation by bootstrapping showed that the population pharmacy model was stable.
Stability and Performance of a Population Pharmacokinetic Model
  • E. Ette
  • Biology
    Journal of clinical pharmacology
  • 1997
TLDR
This study aimed to determine the stability (in terms of covariate selection) of a population pharmacokinetic model and evaluate its performance in the absence of a test data set and found that bootstrap resampling procedure is useful for evaluating the stability and performance of apopulation model by repeatedly fitting it to the bootstrap samples when there is no test dataSet.
Learning versus confirming in clinical drug development
  • L. Sheiner
  • Psychology, Biology
    Clinical pharmacology and therapeutics
  • 1997
Prediction of Creatinine Clearance from Serum Creatinine
A formula has been developed to predict creatinine clearance (Ccr) from serum creatinine (Scr) in adult males: Ccr = (140 – age) (wt kg)/72 × Scr(mg/100ml) (15% less i